The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@Hermes_Paris @LouisVuitton and @Dior all have form when it comes to faux leather. Only those three have the MC mentioned according to the chatter. Any of them will do just fine. #BSFA. See you at 50p.
Investors piling out but still looks overpriced at this level. Expect it will drop to c. 5p which would then make it more attractive consideration
I must have misread somewhere then. Thought it would allow direct investment into a subsidiary by private investors. Instead of having to buy shares here like the rest of us.
They will all be private companies under the BSF umbrella so if you wanted to invest in any of them you would have to invest in BSFA.
If investors are going to be able to invest directly into each subsidiary, then what's the point of BSF? It just sounds abit like ANIC now. No wonder there's no interest. Unless I'm missing something?
Interesting read https://www.euronews.com/culture/2024/01/22/is-fashion-ready-to-say-goodbye-to-leather?utm_source=Twitter&utm_medium=Social
Fantastic thanks Myles. Superb morning reading and really does highlight just hbow undervalued this is
We are on the cusp of something huge
Www.aimchaos.files.wordpress.com/2024/02/04-bsf-enterprise-an-introduction-1.pdf
Hope it's of use to anybody!
I agree we need to get someone on board via some kind of licensing agreement. Surely we are getting nearer to this. My view is something will occur with the leather devision first as this requires less regulatory clearence inmv .As i have posted before. Maybe someone could air their views on this.
Just a thought maybe the company could try and get Peta to be more vocal on this. You never know with an election coming up that the main parties could jump all over this and not just for the leather part .but cultivated meat in reducing green house emmisions.
Need get some deals signed revenue in other wise will just drift as there finance gets spent
Disappointing to see every rise getting sold into. Lets hope the tables turn soon......
What stuck out for me is that the hunt is on for a Ceo for the leather division. I read that as a possitive. My view is that this will be the short term driver with licensing and funding coming forward before the other divisions. The main reason being that it doesnt require the same regulatory clearences for the product from the Fda,Ema,Mhra etc. So in other words not so many hurdles to overcome.
Flexible funding options with the ability for investors or partners to fund an individual subsidiary.
Subsidiary structure better, may make it easier get finance, appear fully funded, All costs money,
So much going on. Its really an exciting play from these levels
Good volume supporting a price increase, good-news RNS is overdue on at least one of the product lines
Looking good
From the 17 Jul 2023 RNS: "The Company has partnered with Benzol - a world leader in the science distribution sector - to help commercialise and act as a distributor of City-MixTM across Germany. Biozol is the leading distributor for some of the leading global pharmaceutical companies, engaging with 14,000 companies across the industry. This partnership forms part of the Company's strategy to use an indirect sales model for the biotech and life sciences markets and partner with appropriate distributors across Europe and the US."
From today's RNS: "Partnered with Benzol to commercialise and distribute City-Mix in Germany. This forms part of the Company's strategy to use an indirect sales model for the biotech and life sciences markets across Europe and the US."
So is this Benzol Lubricants: https://benzollubricants.de/ ?
Or really Biozol Diagnostica Vertrieb GmbH ("Your solution for high quality products and services for life sciences and laboratory diagnostics"): https://www.biozol.de/en ?
🙄
Very clearly says this in the report:
"The Group has prepared monthly cash flow forecasts based on reasonable estimates of key variables including operating costs and capital expenditure through to March 2025 that supports the conclusion of the Directors that they expect sufficient funding to be available to meet the Group's anticipated cash flow requirements to this date."
Pretty much all companies with initial little or no revs so they have to raise at some point, just generic statements.
However as stated above, they have stated they have enough cash for over a year. If any acquisitions come about then they probably will raise but i expect on favourable terms.
Its says clearly in the report when they will need to raise
I think the key here is what comes out in the more indepth plan going forward. What we need is a clear indication of the timescale for the validation studies and what can be expected if succesful. I.E collaborations, mile stone payments and possible orders.For me the leather decision division offers the most hope short term as there should not be so many regulatory hurdles to go through.
2.9 million raised back in March, 1.64 million left, just over 1.2 million spent in 10 months, roughly years money left so no need raise unless acquisition
Take comfort in the BoD's holiday to the US and the CEO's £80k for 2 days a week, because f all else has happened, just more spin.
Some selling into results 3x 10 grands worth